{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:00:37Z","timestamp":1783472437766,"version":"3.55.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sanofi S.A"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,5]]},"abstract":"<jats:p>In response to the vaccine shortage of yellow fever vaccine (YF-VAX) due to manufacturing delays, the unapproved 17D-204 YF-VAX was used as an investigator-initiated clinical trial in Japan. The vaccine was administered to 11\u2009279 participants in 19 YF vaccination centres in Japan, and few serious adverse events were observed.<\/jats:p>","DOI":"10.1093\/jtm\/taac070","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T22:01:06Z","timestamp":1654034466000},"source":"Crossref","is-referenced-by-count":8,"title":["A nationwide prospective cohort study on safety of the 17D-204 yellow fever vaccine during a vaccine shortage in Japan"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1129-0651","authenticated-orcid":false,"given":"Yusuke","family":"Miyazato","sequence":"first","affiliation":[{"name":"Disease Control and Prevention Center , National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Terada","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center , National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mugen","family":"Ujiie","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center , National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Saito","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center , National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinari","family":"Moriya","sequence":"additional","affiliation":[{"name":"Division of Quarantine and Sanitation , Chubu Airport Quarantine Office, Nagoya Quarantine Station, Nagoya 479-0881 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ando","sequence":"additional","affiliation":[{"name":"Sendai Quarantine Station , Sendai 985-0011 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[{"name":"Disease Control and Prevention Center , National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,28]]},"reference":[{"key":"2023040512345056600_","doi-asserted-by":"crossref","first-page":"780","DOI":"10.15585\/mmwr.mm6629a4","article-title":"Update: temporary total depletion of U.S. licensed yellow fever vaccine for civilian travelers addressed by investigational new drug use of imported Stamaril vaccine","volume":"66","author":"Gershman","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023040512345056600_","doi-asserted-by":"crossref","first-page":"457","DOI":"10.15585\/mmwr.mm6617e2","article-title":"Addressing a yellow fever vaccine shortage - United States, 2016-2017","volume":"66","author":"Gershman","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023040512345056600_","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay098","article-title":"Fractional dosing of yellow fever vaccine during shortages: perspective from Canada","volume":"25","author":"Teitelbaum","year":"2018","journal-title":"J Travel Med"},{"key":"2023040512345056600_","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay151","article-title":"Clinical trial with unlicensed yellow fever vaccine in Japan","volume":"26","author":"Ujiie","year":"2019","journal-title":"J Travel Med"},{"key":"2023040512345056600_","article-title":"Stamaril \u2013 Article 30 referral \u2013 Annex I, II, III","author":"European Medicines Agency","year":"2006"},{"key":"2023040512345056600_","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/2168479017694850","article-title":"Overview of FDA's expanded access program for investigational drugs","volume":"51","author":"Jarow","year":"2017","journal-title":"Ther Innov Regul Sci"},{"key":"2023040512345056600_","article-title":"Datapharm \u2013 electronic medicines compendium (emc). Stamaril","author":"Sanofi Pasteur","year":"2020"},{"key":"2023040512345056600_","doi-asserted-by":"crossref","first-page":"taw012","DOI":"10.1093\/jtm\/taw012","article-title":"Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period","volume":"23","author":"Tanizaki","year":"2016","journal-title":"J Travel Med"},{"key":"2023040512345056600_","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17d vaccines (Arilvax and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Monath","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"2023040512345056600_","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4161\/hv.22714","article-title":"Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more","volume":"9","author":"Miyaji","year":"2013","journal-title":"Hum Vaccin Immunother"}],"container-title":["Journal of Travel Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jtm\/advance-article-pdf\/doi\/10.1093\/jtm\/taac070\/44117102\/taac070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/30\/2\/taac070\/49759057\/taac070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jtm\/article-pdf\/30\/2\/taac070\/49759057\/taac070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T13:26:47Z","timestamp":1700659607000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jtm\/article\/doi\/10.1093\/jtm\/taac070\/6594511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,28]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,5,28]]},"published-print":{"date-parts":[[2023,4,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jtm\/taac070","relation":{},"ISSN":["1195-1982","1708-8305"],"issn-type":[{"value":"1195-1982","type":"print"},{"value":"1708-8305","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3]]},"published":{"date-parts":[[2022,5,28]]},"article-number":"taac070"}}